A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate

Patients with triple receptor-negative breast cancer often develop aggressive metastatic disease, which also might involve the brain. In many cases, systemic and local treatment is needed. It is important to consider the toxicity of chemo- and radiotherapy, especially when newly approved drugs becom...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Aandahl, Gro, Dalhaug, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431070/
https://www.ncbi.nlm.nih.gov/pubmed/22953094
http://dx.doi.org/10.1155/2012/537183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431070/
https://www.ncbi.nlm.nih.gov/pubmed/22953094
http://dx.doi.org/10.1155/2012/537183

Ejemplares similares